All In Biotech

Drug Trial Radar · NCT05936580

Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery

Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery - an International, Open-label, Non-controlled Study (NuDIMENSION)

Last checked: Nov 20, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

28

Planned (sponsor's estimate)

Start

May 12, 2026

Primary completion

Feb 2027

Study completion Feb 2027

Sponsor

Lead sponsor
OctapharmaIndustry
Sponsor type
Industry
First posted
Jul 10, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Recombinant factor VIII for the prevention of bleeding in women/girls with haemophilia A undergoing major surgery

Conditions

  • Hemophilia A

Interventions

  • NuwiqDrug

    Nuwiq is a purified B-domain-deleted FVIII glycoprotein synthesised by a genetically engineered human embryonic kidney cell line (HEK 293F).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall haemostatic efficacyTime frame: During surgery and until completion of wound healing (e.g. removal of sutures, cessation of drainage, etc.) as defined by the investigator, during the study duration of 30 ± 3 days after the day of surgical procedure

Locations

17 sites in 10 countries. Site status is shown where the registry gives one.

  • UT Health San Antonio

    San Antonio, Texas · Recruiting

  • Helsinki University Hospital,Coagulation Disorder Unit

    Helsinki, Finland · Recruiting

  • Avenue de la République

    Chambray-lès-Tours, France · Recruiting

  • CHU de Nantes Hôtel-Dieu

    Nantes, France · Recruiting

  • Chu de Strasbourg

    Strasbourg, France · Recruiting

  • Universitätsklinikum Bonn,Institut für Experimentelle Haematologie und Transfusionsmedizin

    Bonn, Germany · Recruiting

  • Gerinnungszentrum Rhein-Ruhr

    Duisburg, Germany · Recruiting

  • Universitätsklinikum Hamburg Eppendorf,II. Medizinische Klinik und Poliklinik

    Hamburg, Germany · Recruiting

  • Aziendo Ospedaliera "Puglieze Ciaccio"

    Catanzaro, Italy · Recruiting

  • Policlinico "P. Giaconne"

    Palermo, Italy · Recruiting

  • Santa Chiara Hospital - APSS

    Trento, Trentino-Alto Adige, Italy · Recruiting

  • Clinical Center for Serbia

    Belgrade, Serbia · Recruiting

  • Hospital Universitario la Paz

    Madrid, Spain · Recruiting

  • Hospital Universitario Virgen del Rocio

    Seville, Spain · Recruiting

  • Insel Spital Bern

    Bern, Switzerland · Recruiting

  • St. James's University Hospital

    Leeds, United Kingdom · Recruiting

  • Centro Hospitalario Pereira Rossell

    Montevideo, Uruguay · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.